4.6 Article

Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study

期刊

THORAX
卷 70, 期 9, 页码 822-829

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2015-206938

关键词

-

资金

  1. Canadian Institute of Heath Research (CIHR/Rx&D Collaborative Research Program) [93326]
  2. Respiratory Health Network of the FRSQ
  3. Canadian Respiratory Research Network (CRRN)
  4. Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health
  5. Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS)
  6. British Columbia Lung Association
  7. Astra Zeneca Canada
  8. Boehringer-Ingelheim Canada
  9. GlaxoSmithKline Canada
  10. Merck
  11. Novartis Pharma Canada
  12. Nycomed Canada
  13. Pfizer Canada

向作者/读者索取更多资源

Background There is limited data on the risk factors and phenotypical characteristics associated with spirometrically confirmed COPD in never-smokers in the general population. Aims To compare the characteristics associated with COPD by gender and by severity of airway obstruction in never-smokers and in ever-smokers. Method We analysed the data from 5176 adults aged 40 years and older who participated in the initial cross-sectional phase of the population-based, prospective, multisite Canadian Cohort of Obstructive Lung Disease study. Never-smokers were defined as those with a lifetime exposure of <1/20 pack year. Logistic regressions were constructed to evaluate associations for 'mild' and 'moderate-severe' COPD defined by FEV1/FVC <5th centile (lower limits of normal). Analyses were performed using SAS V.9.1 (SAS Institute, Cary, North Carolina, USA). Results The prevalence of COPD (FEV1/FVC

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据